Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology
Disease Category: Schizophrenia and Schizoaffective Disorders
Location: United States, IL
A fifteen month, prospective, randomized, active-controlled, open-label, flexible dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia who have been recently released from jail.
This study will compare the effects (both good and bad) of paliperidone palmitate to those of several FDA approved oral antipsychotic medications used to treat schizophrenia.
The purpose of this study is to help understand if paliperidone palmitate or oral antipsychotic medication is better at preventing a worsening of your symptoms of schizophrenia which could cause an unfavorable outcome.
Please contact Alexian Brothers for more information on participation.
Date Last Changed:
July 22, 2013
Alexian Brothers Hospital Network1786 Moon Lake Boulevard, Suite 200Hoffman Estates, IL 60169Phone: 847-230-3599
Research Center Information: Alexian Brothers Hospital Network
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.